Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
The Pharma Data
JANUARY 10, 2021
Boehringer Ingelheim is significantly increasing its investment in a broad range of digital technologies, encompassing key areas such as Artificial Intelligence (AI), machine learning, and data science to better understand diseases, their drivers and biomarkers, and digital therapeutics.
40 
Let's personalize your content